ProCE Banner Activity

Establishing HER2-Targeted Therapies in the Treatment of HER2-Low Breast Cancer

Slideset

Download these slides from a live symposium at ASCO 2023 to learn more about established and emerging targeted therapies for patients with HER2-low breast cancer.

Released: June 02, 2023

Share

Faculty

Shanu Modi

Shanu Modi, MD

Full Member and Professor of Medicine
Breast Medicine Service; Department of Medicine 
Attending Physician 
Medicine 
Memorial Sloan Kettering Cancer Center 
New York, New York 

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Gilead Sciences, Inc.

AstraZeneca

Daiichi Sankyo

Gilead Sciences, Inc.